# Trade Mark Journal No.2026/014 3 April 2026

## UK00004359710 23 March 2026 (1,5,40,42)

WUXITECAN-2

Class 1
  Active chemical ingredients; active chemical ingredients for use in the manufacture of pharmaceuticals; chemical reagents, other than for medical or veterinary purposes; chemical substances for use in the manufacture of pharmaceuticals; biochemical catalysts; biological preparations, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; heterocyclic compounds; chemical substances; chemical materials and chemical preparations; antibody-drug conjugates for use in the manufacture of pharmaceuticals; antibody-drug conjugates other than for medical or veterinary purposes; antibody-drug conjugates for scientific purposes.
Class 5
  Chemical pharmaceutical preparations; medicinal drugs; pharmaceutical preparations for inhibiting tumors; pharmaceutical products for the prevention and treatment of cancer; biological preparations for the treatment of cancer; biological preparations for medical use; medicinal chemical preparations; chemical reagents for medical or veterinary purposes; chemical reagents for medical purposes; antibody-drug conjugates; antibody-drug conjugates for pharmaceutical use; antibody-drug conjugates for the treatment of cancer; pharmaceutical preparations containing antibody-drug conjugates.
Class 40
  Custom assembling of materials for others; Custom manufacturing of pharmaceuticals; Custom manufacturing of drug conjugates; Customized production service of pharmaceuticals; Customized production service of biological preparations; Custom manufacturing of Antibody-drug Conjugates; Processing or treating of chemical reagents; Pharmaceutical processing; Processing of biomedical preparations; Processing of drug conjugates; Processing of antibody drugs; Custom manufacturing of antibody drugs; Processing of biotechnology drug.
Class 42
  Development of products for others; Drug development service; Research and development of new products; Biochemical research and development; Custom design and development of chemical reagent antibodies and conjugate antibodies; Research and development in the field of pharmaceutical biomedicine and biotechnology, especially the research of antibodies including conjugated antibodies; Biomedical research service; Development of pharmaceutical preparations and medicines; Research and development of Antibody-drug Conjugates; Research and development of drug conjugates; Preclinical research and evaluation of new drugs; Consulting services in the field of technology development; Pharmaceutical research services; Scientific research and development; Research and development of antibodies.

WuXi XDC Cayman Inc.

Representative: Brand Murray Fuller LLP